The alveolar immune cell landscape is dysregulated in checkpoint inhibitor pneumonitis
Author:
Funder
NHLBI
U.S. Department of Defense
Publisher
American Society for Clinical Investigation
Subject
General Medicine
Link
https://www.jci.org/articles/view/128654/files/pdf
Reference44 articles.
1. Antagonists of PD-1 and PD-L1 in Cancer Treatment
2. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
3. Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study
4. Pneumonitis from anti-PD-1/ PD-L1 therapy;Balaji;Oncology (Williston Park, NY),2017
5. Immune Checkpoint Immunotherapy for Non-Small Cell Lung Cancer
Cited by 115 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Bronchoalveolar lavage fluid analysis in patients with checkpoint inhibitor pneumonitis;Cancer Immunology, Immunotherapy;2024-09-13
2. Toxicity in the era of immune checkpoint inhibitor therapy;Frontiers in Immunology;2024-08-23
3. Review of T Helper 2-Type Inflammatory Diseases Following Immune Checkpoint Inhibitor Treatment;Biomedicines;2024-08-19
4. The potential role of lung microbiota and lauroylcarnitine in T-cell activation associated with checkpoint inhibitor pneumonitis;eBioMedicine;2024-08
5. The application of bronchoscopy in the assessment of immune checkpoint inhibitor-related pneumonitis severity and recurrence;Scientific Reports;2024-07-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3